{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T19:48:31Z","timestamp":1791402511973,"version":"4.3.3"},"reference-count":50,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2006,10,1]],"date-time":"2006-10-01T00:00:00Z","timestamp":1159660800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,10,1]],"date-time":"2006-10-01T00:00:00Z","timestamp":1159660800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["EY014564"],"award-info":[{"award-number":["EY014564"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DE011390"],"award-info":[{"award-number":["DE011390"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32-DE07165"],"award-info":[{"award-number":["T32-DE07165"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["ES01247"],"award-info":[{"award-number":["ES01247"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["EY017123"],"award-info":[{"award-number":["EY017123"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajp.amjpathol.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Pathology"],"published-print":{"date-parts":[[2006,10]]},"DOI":"10.2353\/ajpath.2006.060434","type":"journal-article","created":{"date-parts":[[2006,12,13]],"date-time":"2006-12-13T14:54:42Z","timestamp":1166021682000},"page":"1183-1193","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":79,"title":["Activated Human T Lymphocytes Express Cyclooxygenase-2 and Produce Proadipogenic Prostaglandins that Drive Human Orbital Fibroblast Differentiation to Adipocytes"],"prefix":"10.1016","volume":"169","author":[{"given":"Steven E.","family":"Feldon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles W.","family":"O'Loughlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise M.","family":"Ray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shira","family":"Landskroner-Eiger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn E.","family":"Seweryniak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard P.","family":"Phipps","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.2353\/ajpath.2006.060434_bib1","first-page":"317","article-title":"Fibroblasts as sentinel cells. Synthesis of chemokines and regulation of inflammation","volume":"151","author":"Smith","year":"1997","journal-title":"Am J Pathol"},{"key":"10.2353\/ajpath.2006.060434_bib2","first-page":"183","article-title":"The myofibroblast: a key cell for wound healing and fibrocontractive diseases","volume":"54","author":"Gabbiani","year":"1981","journal-title":"Prog Clin Biol Res"},{"key":"10.2353\/ajpath.2006.060434_bib3","doi-asserted-by":"crossref","first-page":"286S","DOI":"10.1378\/chest.122.6_suppl.286S","article-title":"The myofibroblast in pulmonary fibrosis","volume":"122","author":"Phan","year":"2002","journal-title":"Chest"},{"key":"10.2353\/ajpath.2006.060434_bib4","first-page":"763","article-title":"Proliferation of alveolar interstitial cells during postnatal lung growth. Evidence for two distinct populations of pulmonary fibroblasts","volume":"127","author":"Brody","year":"1983","journal-title":"Am Rev Respir Dis"},{"key":"10.2353\/ajpath.2006.060434_bib5","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/S0002-9440(10)63488-8","article-title":"Thy-1 expression in human fibroblast subsets defines myofibroblastic or lipofibroblastic phenotypes","volume":"163","author":"Koumas","year":"2003","journal-title":"Am J Pathol"},{"key":"10.2353\/ajpath.2006.060434_bib6","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/jcp.1041180203","article-title":"In vitro characteristics of the lipid-filled interstitial cell associated with postnatal lung growth: evidence for fibroblast heterogeneity","volume":"118","author":"Maksvytis","year":"1984","journal-title":"J Cell Physiol"},{"key":"10.2353\/ajpath.2006.060434_bib7","doi-asserted-by":"crossref","first-page":"12953","DOI":"10.1074\/jbc.270.22.12953","article-title":"An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor \u03b3 (PPAR-\u03b3)","volume":"270","author":"Lehmann","year":"1995","journal-title":"J Biol Chem"},{"key":"10.2353\/ajpath.2006.060434_bib8","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/0092-8674(95)90193-0","article-title":"15-Deoxy-\u039412,14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR-\u03b3","volume":"83","author":"Forman","year":"1995","journal-title":"Cell"},{"key":"10.2353\/ajpath.2006.060434_bib9","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/0092-8674(95)90194-9","article-title":"A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor \u03b3 and promotes adipocyte differentiation","volume":"83","author":"Kliewer","year":"1995","journal-title":"Cell"},{"key":"10.2353\/ajpath.2006.060434_bib10","doi-asserted-by":"crossref","first-page":"5754","DOI":"10.1074\/jbc.275.8.5754","article-title":"A dominant-negative peroxisome proliferator-activated receptor\u03b3 (PPAR-\u03b3) mutant is a constitutive repressor and inhibits PPAR-\u03b3-mediated adipogenesis","volume":"275","author":"Gurnell","year":"2000","journal-title":"J Biol Chem"},{"key":"10.2353\/ajpath.2006.060434_bib11","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.2337\/diabetes.51.7.2045","article-title":"Role of peroxisome proliferator-activated receptor-\u03b3 in maintenance of the characteristics of mature 3T3\u2013L1 adipocytes","volume":"51","author":"Tamori","year":"2002","journal-title":"Diabetes"},{"key":"10.2353\/ajpath.2006.060434_bib12","doi-asserted-by":"crossref","first-page":"10703","DOI":"10.1073\/pnas.0403652101","article-title":"Selective disruption of PPAR-\u03b3 2 impairs the development of adipose tissue and insulin sensitivity","volume":"101","author":"Zhang","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.2353\/ajpath.2006.060434_bib13","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1210\/jcem.87.1.8164","article-title":"Orbital fibroblast heterogeneity may determine the clinical presentation of thyroid-associated ophthalmopathy","volume":"87","author":"Smith","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.2353\/ajpath.2006.060434_bib14","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1161\/01.CIR.0000025403.20953.23","article-title":"Effect of rosiglitazone treatment on nontraditional markers of cardiovascular disease in patients with type 2 diabetes mellitus","volume":"106","author":"Haffner","year":"2002","journal-title":"Circulation"},{"key":"10.2353\/ajpath.2006.060434_bib15","first-page":"776","article-title":"Relationship between disease duration and predominant orbital T cell subset in Graves' ophthalmopathy","volume":"85","author":"Aniszewski","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.2353\/ajpath.2006.060434_bib16","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1006\/clin.1994.1169","article-title":"Immunohistochemical staining of retrobulbar adipose tissue in Graves' ophthalmopathy","volume":"73","author":"Kahaly","year":"1994","journal-title":"Clin Immunol Immunopathol"},{"key":"10.2353\/ajpath.2006.060434_bib17","first-page":"222","article-title":"Immunohistochemical analysis of the retrobulbar tissues in Graves' ophthalmopathy","volume":"75","author":"Weetman","year":"1989","journal-title":"Clin Exp Immunol"},{"key":"10.2353\/ajpath.2006.060434_bib18","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S0161-6420(81)34993-8","article-title":"Correlation of CT scanning and pathologic features of ophthalmic Graves' disease","volume":"88","author":"Trokel","year":"1981","journal-title":"Ophthalmology"},{"key":"10.2353\/ajpath.2006.060434_bib19","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1136\/bjo.84.5.517","article-title":"T cells and fibroblasts in affected extraocular muscles in early and late thyroid associated ophthalmopathy","volume":"84","author":"Pappa","year":"2000","journal-title":"Br J Ophthalmol"},{"key":"10.2353\/ajpath.2006.060434_bib20","first-page":"2620","article-title":"Evidence for cellular heterogeneity in primary cultures of human orbital fibroblasts","volume":"80","author":"Smith","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"10.2353\/ajpath.2006.060434_bib21","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/0090-1229(95)90135-3","article-title":"CD40 expression by human fibroblasts","volume":"77","author":"Fries","year":"1995","journal-title":"Clin Immunol Immunopathol"},{"key":"10.2353\/ajpath.2006.060434_bib22","doi-asserted-by":"crossref","first-page":"3913","DOI":"10.1167\/iovs.05-0605","article-title":"Autologous T-lymphocytes stimulate proliferation of orbital fibroblasts derived from patients with Graves' ophthalmopathy","volume":"46","author":"Feldon","year":"2005","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.2353\/ajpath.2006.060434_bib23","doi-asserted-by":"crossref","first-page":"11988","DOI":"10.1074\/jbc.M011729200","article-title":"DNA synthesis and mitotic clonal expansion is not a required step for 3T3\u2013L1 pre-adipocyte differentiation into adipocytes","volume":"276","author":"Qiu","year":"2001","journal-title":"J Biol Chem"},{"key":"10.2353\/ajpath.2006.060434_bib24","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.biochi.2005.08.010","article-title":"Liver X receptor preferentially activates de novo lipogenesis in human preadipocytes","volume":"88","author":"Darimont","year":"2006","journal-title":"Biochimie"},{"key":"10.2353\/ajpath.2006.060434_bib25","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1053\/meta.2002.34037","article-title":"Comparison of human abdominal subcutaneous versus omental preadipocyte differentiation in primary culture","volume":"51","author":"Shahparaki","year":"2002","journal-title":"Metabolism"},{"key":"10.2353\/ajpath.2006.060434_bib26","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.2337\/diabetes.52.7.1673","article-title":"Expression of peroxisome proliferator-activated receptor-\u03b31 and peroxisome proliferator-activated receptor-\u03b32 in visceral and subcutaneous adipose tissue of obese women","volume":"52","author":"Giusti","year":"2003","journal-title":"Diabetes"},{"key":"10.2353\/ajpath.2006.060434_bib27","doi-asserted-by":"crossref","first-page":"10459","DOI":"10.1074\/jbc.M110314200","article-title":"15-deoxy-\u039412,14-prostaglandin J2. A prostaglandin D2 metabolite generated during inflammatory processes","volume":"277","author":"Shibata","year":"2002","journal-title":"J Biol Chem"},{"key":"10.2353\/ajpath.2006.060434_bib28","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/34184","article-title":"PPAR-\u03b3 agonists inhibit production of monocyte inflammatory cytokines","volume":"391","author":"Jiang","year":"1998","journal-title":"Nature"},{"key":"10.2353\/ajpath.2006.060434_bib29","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.plefa.2005.04.004","article-title":"The transcriptional basis of adipocyte development","volume":"73","author":"Rosen","year":"2005","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"10.2353\/ajpath.2006.060434_bib30","doi-asserted-by":"crossref","first-page":"29615","DOI":"10.1074\/jbc.273.45.29615","volume":"273","author":"Cao","year":"1998","journal-title":"J Biol Chem"},{"key":"10.2353\/ajpath.2006.060434_bib31","doi-asserted-by":"crossref","first-page":"111","DOI":"10.4049\/jimmunol.163.1.111","article-title":"Induction of cyclooxygenase-2 on activated T lymphocytes: regulation of T cell activation by cyclooxygenase-2 inhibitors","volume":"163","author":"Iniguez","year":"1999","journal-title":"J Immunol"},{"key":"10.2353\/ajpath.2006.060434_bib32","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1046\/j.1365-2249.1999.00780.x","article-title":"Cyclooxygenase-1 and \u22122 are expressed by human T cells","volume":"115","author":"Pablos","year":"1999","journal-title":"Clin Exp Immunol"},{"key":"10.2353\/ajpath.2006.060434_bib33","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/nm1005","article-title":"Human lupus T cells resist inactivation and escape death by upregulating COX-2","volume":"10","author":"Xu","year":"2004","journal-title":"Nat Med"},{"key":"10.2353\/ajpath.2006.060434_bib34","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1172\/JCI200318012","article-title":"Biosynthesis of 15-deoxy-\u039412,14-PGJ2 and the ligation of PPAR-\u03b3","volume":"112","author":"Bell-Parikh","year":"2003","journal-title":"J Clin Invest"},{"key":"10.2353\/ajpath.2006.060434_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0952-3278(92)90178-L","article-title":"Biological activities and mechanisms of action of PGJ2 and related compounds: an update","volume":"47","author":"Fukushima","year":"1992","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"10.2353\/ajpath.2006.060434_bib36","doi-asserted-by":"crossref","first-page":"11713","DOI":"10.1016\/S0021-9258(17)44287-6","article-title":"Albumin-catalyzed metabolism of prostaglandin D2. Identification of products formed in vitro","volume":"258","author":"Fitzpatrick","year":"1983","journal-title":"J Biol Chem"},{"key":"10.2353\/ajpath.2006.060434_bib37","doi-asserted-by":"crossref","first-page":"6189","DOI":"10.1158\/0008-5472.CAN-04-4439","article-title":"Suppression of prostate tumor cell growth by stromal cell prostaglandin D synthase-derived products","volume":"65","author":"Kim","year":"2005","journal-title":"Cancer Res"},{"key":"10.2353\/ajpath.2006.060434_bib38","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S1388-1981(02)00322-0","article-title":"Novel prostaglandin D2-derived activators of peroxisome proliferator-activated receptor-\u03b3 are formed in macrophage cell cultures","volume":"1631","author":"Soderstrom","year":"2003","journal-title":"Biochim Biophys Acta"},{"key":"10.2353\/ajpath.2006.060434_bib39","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1210\/er.2002-0020","article-title":"Current perspective on the pathogenesis of Graves' disease and ophthalmopathy","volume":"24","author":"Prabhakar","year":"2003","journal-title":"Endocr Rev"},{"key":"10.2353\/ajpath.2006.060434_bib40","first-page":"3428","article-title":"Evidence of adipocyte differentiation in human orbital fibroblasts in primary culture","volume":"81","author":"Sorisky","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"10.2353\/ajpath.2006.060434_bib41","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/S1097-2765(00)80209-9","article-title":"PPAR-\u03b3 is required for placental, cardiac, and adipose tissue development","volume":"4","author":"Barak","year":"1999","journal-title":"Mol Cell"},{"key":"10.2353\/ajpath.2006.060434_bib42","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.4049\/jimmunol.129.4.1627","article-title":"Prostaglandin D2 generation after activation of rat and human mast cells with anti-IgE","volume":"129","author":"Lewis","year":"1982","journal-title":"J Immunol"},{"key":"10.2353\/ajpath.2006.060434_bib43","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1001\/archopht.123.1.119","article-title":"Rosiglitazone-induced proptosis","volume":"123","author":"Levin","year":"2005","journal-title":"Arch Ophthalmol"},{"key":"10.2353\/ajpath.2006.060434_bib44","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1210\/jc.2002-020987","article-title":"Peroxisome proliferator-activated receptor-\u03b3 in thyroid eye disease: contraindication for thiazolidinedione use?","volume":"88","author":"Starkey","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.2353\/ajpath.2006.060434_bib45","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1046\/j.0019-2805.2001.01340.x","article-title":"Prostaglandin D2, its metabolite 15-d-PGJ2, and peroxisome proliferator activated receptor-gamma agonists induce apoptosis in transformed, but not normal, human T lineage cells","volume":"105","author":"Harris","year":"2002","journal-title":"Immunology"},{"key":"10.2353\/ajpath.2006.060434_bib46","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.4049\/jimmunol.168.3.1372","article-title":"15-Deoxy-\u039412,14-PGJ2 induces IL-8 production in human T cells by a mitogen-activated protein kinase pathway","volume":"168","author":"Harris","year":"2002","journal-title":"J Immunol"},{"key":"10.2353\/ajpath.2006.060434_bib47","doi-asserted-by":"crossref","first-page":"6941","DOI":"10.4049\/jimmunol.165.12.6941","article-title":"Peroxisome proliferator activator receptor-\u03b3agonists and 15-deoxy-\u039412,14-PGJ2 induce apoptosis in normal and malignant B-lineage cells","volume":"165","author":"Padilla","year":"2000","journal-title":"J Immunol"},{"key":"10.2353\/ajpath.2006.060434_bib48","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1006\/clim.2001.5181","article-title":"Human B lymphocytes and B lymphomas express PPAR-\u03b3 and are killed by PPAR-\u03b3 agonists","volume":"103","author":"Padilla","year":"2002","journal-title":"Clin Immunol"},{"key":"10.2353\/ajpath.2006.060434_bib49","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1002\/1521-4141(200202)32:2<477::AID-IMMU477>3.0.CO;2-U","article-title":"Fibroblast subsets in the human orbit: thy-1+ and Thy-1\u2212 subpopulations exhibit distinct phenotypes","volume":"32","author":"Koumas","year":"2002","journal-title":"Eur J Immunol"},{"key":"10.2353\/ajpath.2006.060434_bib50","doi-asserted-by":"crossref","first-page":"C707","DOI":"10.1152\/ajpcell.1998.274.3.C707","article-title":"Human orbital fibroblasts are activated through CD40 to induce proinflammatory cytokine production","volume":"274","author":"Sempowski","year":"1998","journal-title":"Am J Physiol"}],"container-title":["The American Journal of Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944010625916?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944010625916?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T14:15:21Z","timestamp":1757600121000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002944010625916"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,10]]},"references-count":50,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,10]]}},"alternative-id":["S0002944010625916"],"URL":"https:\/\/doi.org\/10.2353\/ajpath.2006.060434","relation":{},"ISSN":["0002-9440"],"issn-type":[{"value":"0002-9440","type":"print"}],"subject":[],"published":{"date-parts":[[2006,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Activated Human T Lymphocytes Express Cyclooxygenase-2 and Produce Proadipogenic Prostaglandins that Drive Human Orbital Fibroblast Differentiation to Adipocytes","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.2353\/ajpath.2006.060434","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}